EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS

Asthma Clinical Trial

Official title:

EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02170883
• Other study ID #: H14-01451
• Status: Completed
• Phase: N/A
• Start date: May 2015
• Est. completion date: March 2019

Study information

• Verified date: December 2020
• Source: University of British Columbia
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Between 8% and 12% of Canadians suffer from asthma. Although there are effective and inexpensive treatments, adherence to asthma treatment is amongst the lowest for all chronic diseases.The purpose of this study is to determine whether enhancing the role of community pharmacists in asthma management using interactive short messaging service (SMS) with asthma patients is a cost-effective model that will improve adherence to inhaled corticosteroid medications compared to usual care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 271
• Est. completion date: March 2019
• Est. primary completion date: March 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 14 Years and older

Eligibility

Inclusion Criteria:

• individuals who fill a (incident or prevalent) prescription for inhaled corticosteroids (either monotherapy or in combination inhaler with long-acting beta-agonists) who have been diagnosed by a doctor as having asthma

• possessing a cell-phone with ability to send/receive text messages

• residing in British Columbia (BC), Canada and planning to reside in BC for the next 12 months

• registered with the medical services plan (MSP, the provincial insure of medically-required services) in the past 12 months, and planning to remain registered for the next 12 months

• designated pharmacy being the main drugstore for patient

• not participating in another interventional study

• consent to participate in the study.

Exclusion Criteria:

• Unable to communicate in English

• Under 14 years of age

Related Conditions & MeSH terms

• Asthma

Intervention

Other:
• Interactive SMS

• Usual care

Locations

Country	Name	City	State
Canada	UBC	Vancouver	British Columbia

Sponsors (4)

Lead Sponsor	Collaborator
University of British Columbia	Canadian Institutes of Health Research (CIHR), College of Pharmacists of British Columbia, WelTel

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Adherence to inhaled corticosteroid medication	Adherence assessed by medication possession ratio	12 months
Secondary	Asthma control	Asthma control assessed by the Asthma Control Test	Baseline
Secondary	Asthma control	Asthma control assessed by the Asthma Control Test	6 months
Secondary	Asthma control	Asthma control assessed by the Asthma Control Test	12 months
Secondary	Quality of life measured by the Asthma Quality of Life Questionnaire	Quality of life measured by the Asthma Quality of Life Questionnaire	Baseline
Secondary	Quality of life measured by the Asthma Quality of Life Questionnaire	Quality of life measured by the Asthma Quality of Life Questionnaire	3 months
Secondary	Quality of life measured by the Asthma Quality of Life Questionnaire	Quality of life measured by the Asthma Quality of Life Questionnaire	12 months
Secondary	Health care resource utilization	Asthma-related hospital admissions and emergency department visits	12 months
Secondary	Use of reliever medication for acute asthma attacks	Use of reliever medication for acute asthma attacks	12 months